- Any of the following within the 6 months prior to the study drug administration:myocardial infraction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure (CHF), cerebrovascular accident or transient ischemic attack, pulmonary embolism.